Stockreport

PTC Therapeutics: Sephience Starts Well, But Translarna Is The Swing Factor [Seeking Alpha]

PTC Therapeutics, Inc.  (PTCT) 
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ptcbio.com
PDF PTCT's near-term upside hinges on FDA approval for Translarna in DMD; a positive decision could drive significant gains, while failure leaves shares fairly valued. Se [Read more]